Recall Radar
All recalls › Medicine & devices

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics,…

Superpotent Drug

Class I Medicine & devices FDA September 23, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. This recall is in the most serious category, meaning the agency believes it can cause serious injury or death — don't finish the package or use up what's left. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
VITRUVIAS THERAPEUTICS INC — Auburn, AL
Severity
Class I — serious
Reported
September 23, 2026
Quantity
1955 bottles
Recall number
D-0866-2026
Status
Ongoing
Source
FDA

Where it went

US Nationwide.

Other medicine & devices recalls

See every current recall on the live dashboard →